BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp. > I'm starting to wonder why the pvt placement hasn't closed

<< Previous

Bullboard Posts

Next >>

Comment by Humaniston Feb 01, 2024 9:21am

56 Views

Post# 35856721

RE:RE: I'm starting to wonder why the pvt placement hasn't closed

true, but htey already closedt with the insiders, i am wondering why the pvt one.. was expectedto closebefore or on jan 26th, it would've been nice to say when they released the nr about hte insdiers that there is adelay or when to expect it etc.. but nothing. that's what worries me..

Mario79 wrote: Insider Report just filed shows one of the officers participated in the private placement. Good sign that things are moving on as they said it would Let's hope for fireworks like we have never seen before.

BioVaxys Technology Corp. (formerly Lions Bay Mining Corp.) $BIOV just filed 3 reports. View full report: SEDI:BIOV #insiders/kenneth-kovan